BHC Bausch Health Companies Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BHC

Price (delayed)

$7.74

Market cap

$2.8B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

$22.98B

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of ...

Highlights
The debt has declined by 8% year-on-year and by 2.1% since the previous quarter
The net income has plunged by 189% from the previous quarter but it has soared by 76% YoY
BHC's EPS has dropped by 187% since the previous quarter but it has surged by 77% year-on-year
The company's equity fell by 32% QoQ
BHC's gross profit is down by 4.6% year-on-year
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.bauschhealth.com
Peers: OCUP

Key stats

What are the main financial stats of BHC
Market
Shares outstanding
362.04M
Market cap
$2.8B
Enterprise value
$22.98B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.34
EV/EBIT
17.38
EV/EBITDA
8.46
EV/Sales
2.83
Earnings
Revenue
$8.12B
EBIT
$1.32B
EBITDA
$2.72B
Free cash flow
-$996M
Per share
EPS
-$0.62
Free cash flow per share
-$2.75
Book value per share
-$1.91
Revenue per share
$22.44
TBVPS
$23.04
Balance sheet
Total assets
$25.69B
Total liabilities
$25.43B
Debt
$20.77B
Equity
-$692M
Working capital
$306M
Liquidity
Debt to equity
-30.01
Current ratio
1.08
Quick ratio
0.6
Net debt/EBITDA
7.43
Margins
EBITDA margin
33.4%
Gross margin
70.9%
Net margin
-2.8%
Operating margin
5.6%
Efficiency
Return on assets
-0.8%
Return on equity
N/A
Return on invested capital
5.3%
Return on capital employed
6.1%
Return on sales
16.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
-2.27%
1 week
1.44%
1 month
-10.42%
1 year
-67.82%
YTD
23.25%
QTD
23.25%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$8.12B
Gross profit
$5.76B
Operating income
$454M
Net income
-$225M
Gross margin
70.9%
Net margin
-2.8%
The net margin has dropped by 190% since the previous quarter but it has surged by 75% year-on-year
The net income has plunged by 189% from the previous quarter but it has soared by 76% YoY
The company's operating income has shrunk by 57% QoQ
The operating margin has plunged by 57% from the previous quarter but it has grown by 6% YoY

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.34
EV/EBIT
17.38
EV/EBITDA
8.46
EV/Sales
2.83
BHC's EPS has dropped by 187% since the previous quarter but it has surged by 77% year-on-year
The company's equity fell by 32% QoQ
The price to sales (P/S) is 61% lower than the 5-year quarterly average of 0.9 and 30% lower than the last 4 quarters average of 0.5
The revenue has declined by 3.7% year-on-year

Efficiency

How efficient is Bausch Health Companies business performance
The ROA has plunged by 189% from the previous quarter but it has soared by 75% YoY
BHC's return on invested capital is down by 23% since the previous quarter
BHC's return on sales is down by 23% since the previous quarter

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
Bausch Health Companies's quick ratio has decreased by 20% YoY but it has increased by 3.4% from the previous quarter
The total liabilities has contracted by 13% YoY
The debt to equity has surged by 86% year-on-year and by 26% since the previous quarter
The company's equity fell by 32% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.